Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biomerica Inc (NQ: BMRA )

5.550 USD +0.050 (+0.91%)
Streaming Delayed Price Updated: 3:14 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biomerica Inc

< Previous 1 2 3 4 Next >
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
From GlobeNewswire News Releases
Biomerica’s Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
From GlobeNewswire News Releases
Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment
From GlobeNewswire News Releases
Biomerica Reports Fiscal 2021 1st Quarter Financial Results
From GlobeNewswire News Releases
Biomerica Reports Fiscal Year End May 31, 2020 Financial Results
From GlobeNewswire News Releases
Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors
From GlobeNewswire News Releases
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
From GlobeNewswire News Releases
Thinking about buying stock in BioNTech, Endeavour Silver Corp, Biomerica, Heat Biologics, or Tonix Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for BNTX, EXK, BMRA, HTBX, and TNXP. 
From PR Newswire
Biomerica Announces Filing of New Three Year Shelf Registration Statement
From GlobeNewswire News Releases
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy (“DGT”) clinical trial
From GlobeNewswire News Releases
Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19
From GlobeNewswire News Releases
Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial
From GlobeNewswire News Releases
Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution
From GlobeNewswire News Releases
Biomerica Announces Third Quarter Financial Results
From GlobeNewswire News Releases
Thinking about buying stock in Biomerica, Co-Diagnostics, Ford, Overstock.com, or Tilray?
InvestorsObserver issues critical PriceWatch Alerts for BMRA, CODX, F, OSTK, and TLRY. 
From PR Newswire
Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs
From GlobeNewswire News Releases
Thinking about buying stock in Blue Apron, BJs Wholesale Club, Biomerica, Cronos Group, or Logitech?
InvestorsObserver issues critical PriceWatch Alerts for APRN, BJ, BMRA, CRON, and LOGI. 
From PR Newswire
Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure
From GlobeNewswire News Releases
Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund
From GlobeNewswire News Releases
Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter
From GlobeNewswire News Releases
Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial
From GlobeNewswire News Releases
Biomerica Reports 1st Quarter Fiscal 2020 Financials
From GlobeNewswire News Releases
Biomerica Announces Fiscal Year End 2019 Financial Results
From GlobeNewswire News Releases
Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia
Biomerica also adds new director of sales and marketing for Europe and South America 
From GlobeNewswire News Releases
Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million
MaxHealth to distribute Biomerica’s colorectal screening test to help identify the early warning signs of colorectal cancer. 
From GlobeNewswire News Releases
New Research: Key Drivers of Growth for Quintana Energy Services, ProQR Therapeutics N.V, Tetraphase Pharmaceuticals, Biomerica, Heat Biologics, and Bellerophon Therapeutics — Factors of Influence, Ma
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Quintana Energy Services Inc.... 
From GlobeNewswire News Releases
Biomerica Announces Third Quarter Financial Results
Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $4,034,822 for the nine months ending February 28, 2019, compared to $4,433,785 for the period ended February 28, 2018. Sales for the three... 
From GlobeNewswire News Releases
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)
– New Allowance by U.S. Patent and Trademark Office Includes irritable bowel syndrome (IBS) test kit panel – 
From GlobeNewswire News Releases
Biomerica Announces Updates for H. Pylori Clinical Studies
Biomerica Inc. (NASDAQ: BMRA) announced today regulatory and clinical advancements in its development program for its H. pylori diagnostic product. 
From GlobeNewswire News Releases
Biomerica Announces Second Quarter Financial Results
Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,500,791 for the three months ended November 30, 2018, compared to $1,613,636 for the same period in the previous year. Net sales were... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.